DE602005025408D1 - Adjuvans von fluorocarbon-emulsionen zur hifu-therapie und verwendung davon - Google Patents

Adjuvans von fluorocarbon-emulsionen zur hifu-therapie und verwendung davon

Info

Publication number
DE602005025408D1
DE602005025408D1 DE602005025408T DE602005025408T DE602005025408D1 DE 602005025408 D1 DE602005025408 D1 DE 602005025408D1 DE 602005025408 T DE602005025408 T DE 602005025408T DE 602005025408 T DE602005025408 T DE 602005025408T DE 602005025408 D1 DE602005025408 D1 DE 602005025408D1
Authority
DE
Germany
Prior art keywords
hifu treatment
enhancement agent
fluoro
target location
core material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005025408T
Other languages
English (en)
Inventor
Zhibiao Wang
Faqi Li
Ziwen Xiao
Yanbing Xiao
Liping Liu
Zhilong Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHONGQING HAIFU MEDICAL TECHNOLOGY CO., LTD, CN
Original Assignee
Chongqing Haifu Hifu Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongqing Haifu Hifu Technology Co Ltd filed Critical Chongqing Haifu Hifu Technology Co Ltd
Publication of DE602005025408D1 publication Critical patent/DE602005025408D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A61K41/0033—Sonodynamic cancer therapy with sonochemically active agents or sonosensitizers, having their cytotoxic effects enhanced through application of ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/226—Solutes, emulsions, suspensions, dispersions, semi-solid forms, e.g. hydrogels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Acoustics & Sound (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE602005025408T 2005-01-10 2005-09-02 Adjuvans von fluorocarbon-emulsionen zur hifu-therapie und verwendung davon Active DE602005025408D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN200510000343A CN100574809C (zh) 2005-01-10 2005-01-10 一种高强度聚焦超声治疗用氟碳乳剂类助剂及其应用
PCT/CN2005/001391 WO2006072200A1 (fr) 2005-01-10 2005-09-02 Adjuvant d’emulsions au fluorocarbure pour un traitement hifu et utilisation de celui-ci

Publications (1)

Publication Number Publication Date
DE602005025408D1 true DE602005025408D1 (de) 2011-01-27

Family

ID=36647408

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005025408T Active DE602005025408D1 (de) 2005-01-10 2005-09-02 Adjuvans von fluorocarbon-emulsionen zur hifu-therapie und verwendung davon

Country Status (13)

Country Link
US (1) US20080138290A1 (de)
EP (1) EP1839677B1 (de)
JP (1) JP2008526786A (de)
KR (1) KR20070094621A (de)
CN (1) CN100574809C (de)
AT (1) ATE491476T1 (de)
AU (1) AU2005324273B2 (de)
BR (1) BRPI0518494A2 (de)
CA (1) CA2593644C (de)
DE (1) DE602005025408D1 (de)
ES (1) ES2355038T3 (de)
RU (1) RU2388492C2 (de)
WO (1) WO2006072200A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2948024B1 (fr) * 2009-07-17 2020-01-10 Centre National De La Recherche Scientifique - Cnrs - Emulsion activable par ultrasons et son procede de fabrication.
WO2013059358A2 (en) 2011-10-17 2013-04-25 Butterfly Network, Inc. Transmissive imaging and related apparatus and methods
US9667889B2 (en) 2013-04-03 2017-05-30 Butterfly Network, Inc. Portable electronic devices with integrated imaging capabilities
CN103877598B (zh) * 2014-03-18 2016-04-27 苏晓婷 一种超声造影剂及其制备方法
CN105330786B (zh) * 2014-07-03 2017-07-14 重庆海扶医疗科技股份有限公司 一种治疗用超声耦合介质材料及其制备方法
CN105169420B (zh) * 2015-09-02 2018-01-05 上海市第十人民医院 一种新型射频诊疗剂及其制备方法
FR3082422B1 (fr) * 2018-06-14 2021-01-22 Univ D'avignon Et Des Pays De Vaucluse Emulsion pour la chirurgie d'ablation ultrasonore

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5832829A (ja) * 1981-08-22 1983-02-25 Green Cross Corp:The 血管造影剤
US4767610A (en) * 1984-10-19 1988-08-30 The Regents Of The University Of California Method for detecting abnormal cell masses in animals
US4987154A (en) * 1986-01-14 1991-01-22 Alliance Pharmaceutical Corp. Biocompatible, stable and concentrated fluorocarbon emulsions for contrast enhancement and oxygen transport in internal animal use
US6551576B1 (en) * 1989-12-22 2003-04-22 Bristol-Myers Squibb Medical Imaging, Inc. Container with multi-phase composition for use in diagnostic and therapeutic applications
US6613306B1 (en) * 1990-04-02 2003-09-02 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
DE4127442C2 (de) * 1991-08-17 1996-08-22 Udo Dr Gros Wäßrige Dispersion Fluorcarbon enthaltender Phospholipid-Vesikel und ein Verfahren zu ihrer Herstellung
US5196183A (en) * 1991-12-04 1993-03-23 Sterling Winthrop Inc. Contrast agents for ultrasound imaging
US5716597A (en) * 1993-06-04 1998-02-10 Molecular Biosystems, Inc. Emulsions as contrast agents and method of use
CA2185810A1 (en) * 1994-03-28 1995-10-05 Jo Klaveness Liposomes
US5605934A (en) * 1995-03-23 1997-02-25 Baxter International Inc. Method of manufacturing and storing solutions
US6165442A (en) * 1996-02-19 2000-12-26 Nycomed Imaging As Thermally stabilized ultrasound contrast agent
WO1997029783A1 (en) * 1996-02-19 1997-08-21 Nycomed Imaging A/S Improvements in or relating to contrast agents
US5846517A (en) * 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
US6548047B1 (en) * 1997-09-15 2003-04-15 Bristol-Myers Squibb Medical Imaging, Inc. Thermal preactivation of gaseous precursor filled compositions
CN1194763C (zh) * 2002-09-06 2005-03-30 中国人民解放军第三军医大学 新型脂质体超声造影剂及其制备方法

Also Published As

Publication number Publication date
RU2388492C2 (ru) 2010-05-10
CA2593644C (en) 2011-06-07
KR20070094621A (ko) 2007-09-20
ES2355038T3 (es) 2011-03-22
BRPI0518494A2 (pt) 2008-11-25
EP1839677A1 (de) 2007-10-03
JP2008526786A (ja) 2008-07-24
EP1839677A4 (de) 2008-03-19
EP1839677B1 (de) 2010-12-15
AU2005324273A1 (en) 2006-07-13
WO2006072200A1 (fr) 2006-07-13
RU2007127668A (ru) 2009-01-27
AU2005324273B2 (en) 2008-08-14
US20080138290A1 (en) 2008-06-12
ATE491476T1 (de) 2011-01-15
CN1803196A (zh) 2006-07-19
CN100574809C (zh) 2009-12-30
CA2593644A1 (en) 2006-07-13

Similar Documents

Publication Publication Date Title
DE602005025408D1 (de) Adjuvans von fluorocarbon-emulsionen zur hifu-therapie und verwendung davon
ATE478683T1 (de) Teilchenförmiges adjuvans für hifu-therapie und seine verwendung
DE502005002436D1 (de) Endochirurgischer bergebeutel für die aufnahme von körpergewebe oder -flüssigkeit
DE602004010407D1 (de) Fluorsubstituierter omega-carboxyaryldiphenylharnstoff zur behandlung und prävention von krankheiten und leiden
JP2008503275A5 (de)
DE60314013D1 (de) 2-(1h-indazol-6-ylamino)- benzamid-verbindungen als protein kinase inhibitoren und deren verwendung zur behandlung von ophthalmischen krankheiten
DE60236413D1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
DE602004025463D1 (de) Verwendung von ciclesonide zur erhaltung des feinen teilchengrössenanteils von formoterol
ATE482981T1 (de) Wässrige monomeremulsionen enthaltend hydrophobin
FR2885536B1 (fr) Composition a base d'ethers de dianhydrohexitol pour le traitement d'une matiere autre que le corps humain
WO2006067715A3 (en) Method for controlling the flow of liquids containing biological material by inducing electro- or magneto-rheological effect
ATE227147T1 (de) Magnetfeldapplikator zur aufheizung von magnetischen oder magnetisierbaren substanzen oder festkorpern in biologischem gewebe
WO2009070442A3 (en) Fc receptor-mediated tumor necrosis factor superfamily mrna expression in peripheral blood leukocytes
ATE497737T1 (de) Implantate beschichtet mit aptameren, die die adhäsion von endothelialen vorläuferzellen vermitteln
ATE537805T1 (de) Herstellung und verwendung eines medizinprodukts in der alternativen medizin zur rehabilitationsbehandlung bei chronischen ekrankungen
DE602004019522D1 (de) Emulsion
WO2006024020A3 (en) Hcv non-structural protein mutants and uses thereof
DE502005010180D1 (de) Copolymerisate und ihre verwendung zur behandlung von flexiblen substraten
WO2008077096A3 (en) Ultrasonic bath to increase tissue perfusion
DE502005011130D1 (de) Verbesserung des einschleif- und anstempelverhaltens von brillengläsern mit hydrophober beschichtung
ATE386572T1 (de) Kosmetische und dermatologische emulsionen
DE50308460D1 (de) Verwendung von ambroxol zur behandlung von chronischen schmerzen
JP2003250831A (ja) 使い捨てカイロ用袋体
CA2540439A1 (en) Low frequency vibration assisted blood perfusion emergency system
ATE498391T1 (de) Flüssige zusammensetzung für die behandlung und/oder verhinderung von verschiedenen metabolischen knochenkrankheiten, verwendung davon und vorbereitungsprozess.

Legal Events

Date Code Title Description
R082 Change of representative

Ref document number: 1839677

Country of ref document: EP

Representative=s name: BLUMBACH ZINNGREBE, DE

R081 Change of applicant/patentee

Ref document number: 1839677

Country of ref document: EP

Owner name: CHONGQING HAIFU MEDICAL TECHNOLOGY CO., LTD, CN

Free format text: FORMER OWNER: CHONGQING HAIFU (HIFU) TECHNOLOGY CO., LTD., CHONGQING, CN

Effective date: 20121120

R082 Change of representative

Ref document number: 1839677

Country of ref document: EP

Representative=s name: BLUMBACH ZINNGREBE, DE

Effective date: 20121120